Dr. Matthew Meriweather, MD

Dr. Meriweather practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

Dr. Meriweather's NPI, 1790218956, was assigned on April 5, 2017. Dr. Meriweather holds Tennessee license 63633.

Dr. Meriweather's primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.

Dr. Meriweather's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. Dr. Meriweather is also affiliated with Cookeville Regional Medical Center. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Meriweather to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Meriweather practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Meriweather's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Meriweather is licensed in Tennessee.

CMS data shows 453 Medicare services from Dr. Meriweather across 7 procedure codes in 2024, for 270 Medicare patients. Medicare paid $37,573 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 270 Medicare patients who saw Dr. Meriweather in 2024. The largest group is 65 to 74, with 116 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Meriweather's median patient age at 68, with 48% women.

In 2022, Dr. Meriweather wrote 18 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $222 in total drug cost. In 2021, CMS named 54 claims across 4 drugs.

Dr. Meriweather accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Meriweather. Dr. Meriweather's most frequent co-authors are Bassel Abou-Khalil, MD and Hasan Huseyin Sonmezturk, MD.

CMS Open Payments shows 9 general payments to Dr. Meriweather from 4 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $160.